SSY Group Limited is one of the leading pharmaceutical manufacturers in China with over 7 decades of operation history and a well-established brand name. The Group is principally engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials.
The Group's production lines have combined the world's most advanced equipments and technologies, achieved full automation and information in production and logistics processes, and reached the international advanced level. The Group has distinct advantages in green production including low-cost, low-power consumption and zero-pollution.
The Group regards the product quality as our lives, and strictly follows the GMP requirements in organisation of production. It establishes and implements superior ideas and initiatives in services, and guarantees the health of many patients, both domestic and international, with excellent product quality and service.
The Group went public on the Hong Kong Stock Exchange in December 2005 with stock code 2005.
updated 31st October, 2023
| © Copyright 1996-2024 irasia.com Ltd. All rights reserved. |
|
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website. |